Obsessive-Compulsive Disorder Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Obsessive-Compulsive Disorder Clinical Trials Market Report Overview
The Obsessive-Compulsive Disorder clinical trial market research report provides an overview of the Obsessive-Compulsive Disorder clinical trials scenario. The report provides top-line data relating to the clinical trials on Obsessive-Compulsive Disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
Key Countries | The US, Iran, China, Canada, India, Russia, Netherlands, France, Japan, and the United Kingdom |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, Viatris Inc, Torrent Investments Pvt Ltd, The Lundbeck Foundation, Syneos Health Inc, AstraZeneca Plc, AbbVie Inc, and Byondis BV |
Obsessive-Compulsive Disorder Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Obsessive-Compulsive Disorder clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America among others. As of April 2023, the majority of the clinical trials were conducted in North America.
The US, Iran, China, Canada, India, Russia, Netherlands, France, Japan, and the United Kingdom are some of the key countries in the Obsessive-Compulsive Disorder clinical trials market. In the country wise analysis, the US has the highest number of Obsessive-Compulsive Disorder clinical trials, as of April 2023, followed by Iran and China.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of Obsessive-Compulsive Disorder to Central Nervous System clinical trials as of April 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Obsessive-Compulsive Disorder to Central Nervous System clinical trials as of April 2023.
Obsessive-Compulsive Disorder Clinical Trials Analysis by Regions, 2023 (%)For more regional insights into the Obsessive-Compulsive Disorder clinical trials market, download a free report sample
Obsessive-Compulsive Disorder Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Obsessive-Compulsive Disorder clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
Obsessive-Compulsive Disorder Clinical Trials Market Analysis by Sponsor Types, 2023 (%) For more sponsor type insights into the Obsessive-Compulsive Disorder clinical trials market, download a free report sample
Obsessive-Compulsive Disorder Clinical Trials Market - Competitive Landscape
The leading sponsors in the Obsessive-Compulsive Disorder clinical trials market are F. Hoffmann-La Roche Ltd, Pfizer Inc, Novartis AG, Viatris Inc, Torrent Investments Pvt Ltd, The Lundbeck Foundation, Syneos Health Inc, AstraZeneca Plc, AbbVie Inc, and Byondis BV among others. As of April 2023, F. Hoffmann-La Roche Ltd sponsored the highest number of Obsessive-Compulsive Disorder trials.
Obsessive-Compulsive Disorder Clinical Trials Market Analysis by Sponsors, 2023 (%)To know more about the leading players in the Obsessive-Compulsive Disorder clinical trials market, download a free report sample
Segments Covered in the Report
Obsessive-Compulsive Disorder Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Obsessive-Compulsive Disorder Clinical Trials Country Outlook (2023)
- The US
- China
- The UK
- Germany
- France
- Spain
Obsessive-Compulsive Disorder Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies regarding investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Pfizer Inc
Novartis AG
Viatris Inc
The Lundbeck Foundation
Torrent Investments Pvt Ltd
AbbVie Inc
AstraZeneca Plc
Syneos Health Inc
Byondis BV
Table of Contents
Table
Figures
Frequently asked questions
-
Which region dominated the Obsessive-Compulsive Disorder clinical trials market share?
As of April 2023, North America dominated the Obsessive-Compulsive Disorder clinical trials market share.
-
Which country had the largest in the Obsessive-Compulsive Disorder clinical trials market size?
As of April 2023, the US had the largest Obsessive-Compulsive Disorder clinical trials market size.
-
What are the key sponsor types in the Obsessive-Compulsive Disorder clinical trials market?
The key sponsor types in the Obsessive-Compulsive Disorder clinical trials market are institution, company, and the government.
-
Who was the leading sponsor in the Obsessive-Compulsive Disorder clinical trials market?
As of April 2023, F. Hoffmann-La Roche Ltd sponsored the highest number of obsessive-compulsive disorder clinical trials.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.